Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person SMAD2 W422* [cytosol]

Class:Id	EntityWithAccessionedSequence:9668736
_displayName	SMAD2 W422* [cytosol]
_timestamp	2019-11-29 16:07:20
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9668726] Orlic-Milacic, Marija, 2019-11-29
crossReference	[DatabaseIdentifier:9668752] COSMIC:COSV50996743 [DatabaseIdentifier:9668751] COSMIC:COSV50998758
disease	[Disease:1500689] cancer [Disease:2327993] hepatocellular carcinoma [Disease:1248674] large intestine cancer [Disease:2328199] basal cell carcinoma
endCoordinate	467
hasModifiedResidue	[NonsenseMutation:9668720] Nonsense mutation at L-tryptophan 422
modified	[InstanceEdit:9668764] Orlic-Milacic, Marija, 2019-11-29
name	SMAD2 W422* SMAD2 W422TER SMAD2 Trp422* SMAD2 Trp422TER
referenceEntity	[ReferenceGeneProduct:405890] UniProt:Q15796 SMAD2 [Homo sapiens]
species	[Species:48887] Homo sapiens
stableIdentifier	[StableIdentifier:9668741] R-HSA-9668736.1
startCoordinate	2
(hasCandidate)	[CandidateSet:3304386] SMAD2 Phosphorylation Motif Mutants [cytosol] [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by SMAD2 W422* [cytosol] (9668736)